Lexaria Bioscience announces the appointment of Nelson Cabatuan, CPA, as CFO, effective immediately. As a member of the executive leadership team, Mr. Cabatuan will lead the Company’s financial operations. Cabatuan has over 15 years of corporate finance and operations experience within the life sciences industry, most recently serving as SVP Finance and Operations at Rain Oncology, Inc., a late-stage precision oncology biotech company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LEXX:
- Lexaria Bioscience files to sell 1.61M shares of common stock for holders
- Lexaria Bioscience Advances Oral Diabetes Treatment
- Lexaria Bioscience hires CRO for GLP-1 human pilot study
- Lexaria Tests New Diabetes and Weight Loss Formulations
- Lexaria Bioscience price target raised to $12 from $3 at Maxim
